Rockefeller Capital Management L.P. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$10
-99.9%
8,8860.0%0.00%
Q3 2022$14,000
+27.3%
8,8860.0%0.00%
Q2 2022$11,000
-21.4%
8,8860.0%0.00%
Q1 2022$14,000
-46.2%
8,886
-31.0%
0.00%
Q4 2021$26,000
-46.9%
12,8860.0%0.00%
Q3 2021$49,000
+48.5%
12,886
+24.1%
0.00%
Q2 2021$33,000
+725.0%
10,386
+419.3%
0.00%
Q1 2021$4,0000.0%2,0000.0%0.00%
Q4 2020$4,000
-20.0%
2,0000.0%0.00%
Q3 2020$5,000
-16.7%
2,0000.0%0.00%
Q2 2020$6,000
+50.0%
2,0000.0%0.00%
Q1 2020$4,000
-33.3%
2,0000.0%0.00%
Q4 2019$6,0002,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders